Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Antibiotics increase risk of hearing loss in patients with deadly bacterial infections

  • Changing clocks, changing seasons: Scientists find role for neuronal plasticity

  • Genetic tug of war in the brain influences parental control over offspring behavior

  • Generally accepted tools used to select patients for aneurysm treatment in need of further evaluation

  • Analysis of post deployment health assessment forms indicates risks of alcohol abuse among service members returning from deployment

  • Parents inclined to misjudge child happiness based on personal feelings

  • Young adults with autism show improved social function following skills program

  • Discovery about brain protein causes rethink on development of Alzheimer's disease

  • Getting to the bottom of aging

  • Perfectionism linked to burnout at work, school and sports, research finds

  •